MeSH tree: C04.557.470.200
Since its development at the University of Michigan more than two decades ago, histotripsy has progressed from an experimental method for mechanically destroying tissue to a US Food and Drug Administration (FDA)–cleared treatment ...
Aug 13, 2026
0
3
Researchers at Tel Aviv University have developed a new method for diagnosing lung cancer: a simple, fast, low-cost blood test that does not require DNA sequencing. The method identifies a chemical fingerprint of cancer cells ...
Aug 10, 2026
0
47
Liver cancer experts at the Johns Hopkins Kimmel Cancer Center and 16 other cancer centers have compiled new guidance on the best treatments for hepatocellular carcinoma (HCC) in North America. The resource, called BEACON-HCC, ...
Aug 10, 2026
0
2
Chemotherapy remains a cornerstone of treatment for head and neck cancers, the seventh-most-common type of cancer worldwide. However, the disease is often diagnosed at a late stage, once it has already spread to other organs, ...
Aug 6, 2026
0
6
Researchers at The University of Texas MD Anderson Cancer Center have discovered that immunosuppressed patients with non-melanoma skin cancer are not missing the key cancer-fighting immune cells found in immunocompetent patients, ...
Aug 5, 2026
0
6
A Singapore team of clinician-scientists and researchers has developed a new tool that accurately predicts which liver cancer patients are likely to experience a recurrence after surgery. The machine-learning tool combines ...
Aug 3, 2026
0
9
Researchers at the Johns Hopkins Kimmel Cancer Center validated an artificial intelligence (AI)-powered blood test that accurately detected liver cancer in people from two geographically and biologically distinct populations ...
Jul 31, 2026
0
9
Biological sex factors into cancer in ways you might not expect. In lung cancer, a form called squamous cell carcinoma disproportionately affects male patients, while adenocarcinoma occurs more frequently in female patients. ...
Jul 21, 2026
0
2
Who doesn't want cancer testing results at lower cost, with greater speed and accuracy? Interdisciplinary innovators like Cancer Center at Illinois (CCIL) program leader Brian Cunningham are among the pioneers of the emerging ...
Jul 21, 2026
0
7
Researchers at The University of Texas MD Anderson Cancer Center identified an immune pathway that may promote the progression of oral precancerous lesions into head and neck squamous cell carcinoma. These results provide ...
Jul 17, 2026
0
6
